Who owns Breath Therapeutics?

Breath Therapeutics is formerly owned by Sofinnova Partners, through Sofinnova Capital VIII, since 2016.

When did Sofinnova Partners acquire Breath Therapeutics?

Sofinnova Partners acquired Breath Therapeutics in 2016 and exited after 3 years.

Has Breath Therapeutics been sold?

Yes. Breath Therapeutics was exited in 2019 via Trade Sale.

Home/Companies/Biotech/Breath Therapeutics

Breath Therapeutics

Biotech·

Germany·Exited 2019·Held 3yr

Breath Therapeutics is a healthcare / biotech company, headquartered in Germany.

Entry

2016

Hold

3yr

Exit

2019

Est. EV

–

Most recent investor

Sofinnova Partners

2 ownership periods

Key facts

HQGermany

SectorHealthcare / Biotech

Inhaled therapeutics biotech. Acquired by Zambon in 2019 Acquired by Zambon Sep 2019 for EUR140M plus milestones.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from Sofinnova Capital VIII

Other portfolio companies in the same fund.

Corvidia Therapeutics

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings